We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
-0.28%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$11B
AUM Growth
-$867M
Cap. Flow
-$754M
Cap. Flow %
-6.85%
Top 10 Hldgs %
42.7%
Holding
720
New
162
Increased
201
Reduced
203
Closed
106

Sector Composition

Rank Sector Weight
1 Financials 32.09%
2 Energy 15.02%
3 Materials 10.86%
4 Healthcare 10.34%
5 Industrials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REXX
601
DELISTED
Rex Energy Corporation
REXX
$69K ﹤0.01%
+1,230
New +$61.1K
GORO icon
602
Goldgroup Mining Inc.
GORO
$211M
$68K ﹤0.01%
24,600
-52,000
-68% -$167K
CARM
603
DELISTED
Carisma Therapeutics
CARM
$65K ﹤0.01%
+1,155
New +$163K
MCHX icon
604
Marchex
MCHX
$77.5M
$65K ﹤0.01%
+13,200
New +$61.9K
FRTX
605
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$63K ﹤0.01%
29
MDR
606
DELISTED
McDermott International
MDR
$62K ﹤0.01%
+3,867
New +$60.4K
AVEO
607
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$56K ﹤0.01%
3,200
-3,960
-55% -$71.3K
HGG
608
DELISTED
hhgregg Inc.
HGG
$50K ﹤0.01%
+14,900
New +$71.2K
SIRI icon
609
SiriusXM
SIRI
$9.59B
$48K ﹤0.01%
1,280
VXRT
610
DELISTED
Vaxart
VXRT
$46K ﹤0.01%
2,036
-55
-3% -$1.35K
OPCH icon
611
Option Care Health
OPCH
$3.57B
$40K ﹤0.01%
+2,725
New +$46.1K
LF
612
DELISTED
LEAPFROG ENTERPRISES INC.
LF
$40K ﹤0.01%
+28,500
New +$58.2K
PLX icon
613
Protalix BioTherapeutics
PLX
$211M
$35K ﹤0.01%
+1,780
New +$36.9K
ANAD
614
DELISTED
ANADIGICS INC
ANAD
$8K ﹤0.01%
10,600
AIR icon
615
AAR Corp
AIR
$5.96B
-15,300
Closed -$470K
AXP icon
616
American Express
AXP
$232B
-4,400
Closed -$344K
BTE icon
617
Baytex Energy
BTE
$3.05B
-3,964,245
Closed -$62.7M
CAT icon
618
Caterpillar
CAT
$393B
-33,200
Closed -$2.66M
CI icon
619
Cigna
CI
$73.3B
-2,050
Closed -$265K
CLDT
620
Chatham Lodging
CLDT
$590M
-17,700
Closed -$521K
CLDX icon
621
Celldex Therapeutics
CLDX
$3.52B
-1,380
Closed -$577K
CODI icon
622
Compass Diversified
CODI
$908M
-17,700
Closed -$303K
CRD.B icon
623
Crawford & Co Class B
CRD.B
$589M
-10,900
Closed -$94K
DLTR icon
624
Dollar Tree
DLTR
$24.7B
-5,700
Closed -$462K
DOC icon
625
Healthpeak Properties
DOC
$14.2B
-6,588
Closed -$259K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q2 2015 Portfolio in Review

As of Q2 2015, Connor, Clark & Lunn Investment Management (CC&L) held 720 positions worth $11B, down 7.3% from $11.9B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $754M in Q2 2015, closing 106 positions and reducing 203 holdings. Its most notable exit was Baytex Energy, an estimated $62.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 30% a quarter earlier, followed by Energy and Materials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Concordia International Corp. Common Stock worth $111M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q2 2015 buy was Concordia International Corp. Common Stock: 1,537,597 shares worth $111M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Turquoise Hill Resources Ltd in Q2 2015, an estimated $66.2M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q2 2015 reduction was Magna International, cutting an estimated $173M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Baytex Energy in Q2 2015, selling an estimated $62.7M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 43% of its $11B portfolio in Q2 2015.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 162 new positions and closed 106 in Q2 2015.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 7.3% quarter-over-quarter to $11B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2015, filed 14 Aug 2015.